PRTC
Price
$28.75
Change
+$1.60 (+5.89%)
Updated
May 10, 6:59 PM EST
37 days until earnings call
RLMD
Price
$3.53
Change
-$0.27 (-7.11%)
Updated
May 10, 6:59 PM EST
87 days until earnings call
Ad is loading...

PRTC vs RLMD

Header iconPRTC vs RLMD Comparison
Open Charts PRTC vs RLMDBanner chart's image
PureTech Health
Price$28.75
Change+$1.60 (+5.89%)
VolumeN/A
CapitalizationN/A
Relmada Therapeutics
Price$3.53
Change-$0.27 (-7.11%)
Volume$39.75K
CapitalizationN/A
View a ticker or compare two or three
PRTC vs RLMD Comparison Chart

Loading...

RLMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PRTC vs. RLMD commentary
May 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRTC is a Hold and RLMD is a Sell.

COMPARISON
Comparison
May 12, 2024
Stock price -- (PRTC: $27.46 vs. RLMD: $3.53)
Brand notoriety: PRTC and RLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRTC: 109% vs. RLMD: 52%
Market capitalization -- PRTC: $751.87M vs. RLMD: $106.51M
PRTC [@Biotechnology] is valued at $751.87M. RLMD’s [@Biotechnology] market capitalization is $106.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $568.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRTC’s FA Score shows that 1 FA rating(s) are green whileRLMD’s FA Score has 1 green FA rating(s).

  • PRTC’s FA Score: 1 green, 4 red.
  • RLMD’s FA Score: 1 green, 4 red.
According to our system of comparison, PRTC is a better buy in the long-term than RLMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLMD’s TA Score shows that 4 TA indicator(s) are bullish.

  • RLMD’s TA Score: 4 bullish, 4 bearish.

Price Growth

PRTC (@Biotechnology) experienced а -3.55% price change this week, while RLMD (@Biotechnology) price change was -4.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.77%. For the same industry, the average monthly price growth was -5.00%, and the average quarterly price growth was +67.78%.

Reported Earning Dates

PRTC is expected to report earnings on Jun 18, 2024.

RLMD is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (-1.77% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for PRTC with price predictions.
OPEN
A.I.dvisor published
a Summary for RLMD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PRTC($752M) has a higher market cap than RLMD($107M). PRTC YTD gains are higher at: -2.555 vs. RLMD (-14.734).
PRTCRLMDPRTC / RLMD
Capitalization752M107M703%
EBITDAN/AN/A-
Gain YTD-2.555-14.73417%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
RLMD: Fundamental Ratings
RLMD
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLMD
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
RLMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFVSX18.280.07
+0.38%
MassMutual Equity Opports R5
DFSRX23.060.05
+0.22%
Delaware Select Growth R
FDVLX15.44-0.01
-0.06%
Fidelity Value
ZSCCX34.74-0.04
-0.12%
Zacks Small-Cap Core Inv
PNSAX67.10-0.35
-0.52%
Putnam Small Cap Growth A

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and RLMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and RLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
N/A
RLMD - PRTC
31%
Poorly correlated
-7.11%
IMUX - PRTC
26%
Poorly correlated
+2.42%
NGM - PRTC
24%
Poorly correlated
N/A
IMMX - PRTC
24%
Poorly correlated
N/A
VYGR - PRTC
23%
Poorly correlated
N/A
More

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with CYTK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
-7.11%
CYTK - RLMD
38%
Loosely correlated
-3.00%
SYRE - RLMD
36%
Loosely correlated
+4.94%
ALVR - RLMD
35%
Loosely correlated
-3.78%
PRTC - RLMD
31%
Poorly correlated
N/A
AVXL - RLMD
31%
Poorly correlated
-1.80%
More